[Cardiac amyloidosis : a rare disease ?]

Area of Science:

• Cardiology
• Cardiovascular Diseases
• Infiltrative Cardiomyopathies

Background:

• Cardiac amyloidosis is a progressive infiltrative cardiomyopathy often leading to heart failure with preserved ejection fraction.
• Causes include genetic mutations, neoplasia (in younger patients), and a prevalent non-genetic form in older adults (formerly senile amyloidosis).
• Late-stage disease carries a poor prognosis, underscoring the need for early detection.

Purpose of the Study:

• To highlight the importance of early diagnosis of cardiac amyloidosis.
• To emphasize the diagnostic utility of bone scintigraphy.
• To advocate for a proactive diagnostic strategy in light of emerging therapies.

Main Methods:

• Review of diagnostic approaches for cardiac amyloidosis.
• Evaluation of bone scintigraphy as a sensitive diagnostic tool.
• Consideration of emerging disease-modifying therapies.

Main Results:

• Cardiac amyloidosis is more prevalent than previously thought.
• Bone scintigraphy is a recognized sensitive method for diagnosing cardiac amyloidosis.
• Early detection is critical due to poor prognosis in advanced stages.

Conclusions:

• A high index of suspicion and thorough initial work-up are essential for timely diagnosis.
• Bone scintigraphy offers a standardized and sensitive diagnostic pathway.
• The availability of new therapies justifies a more aggressive diagnostic approach to cardiac amyloidosis.